Edit |   |
---|---|
Product Name | Recombinant human Aldo-keto reductase 7A2/AKR7A2 protein |
Description | Domain: 1-359aa. Recombinant AKR7A2 protein was expressed in E. coli and purified by using conventional chromatography techniques. MW: 44 kDa (398aa) confirmed by MALDI-TOF. Purity > 90% by SDS-PAGE. Aldo-keto reductases, such as AKR7A2, are involved in the detoxification of aldehydes and ketones. This protein can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the nonbinding AFB1 dialcohol. It may be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen. Also, it has been proposed previously to catalyze the NADPH-dependent reduction of succinic semialdehyde (SSA) to gamma-Hydroxybutyrate in human brain |
Size | 20ug, 100ug, 500ug |
Concentration | 0.5mg/ml (determined by Bradford assay) |
Applications | SDS-PAGE, Enzyme Activity |
Other Names | Aldo-keto reductase family 7 member A2, Aflatoxin B1 aldehyde reductase member 2, AFB1 aldehyde reductase 1 (AFB1-AR 1), Aldoketoreductase 7, Succinic semialdehyde reductase (SSA reductase), AFAR, AFAR1, AKR7 |
Gene, Accession, CAS # | NCBI: NP_003680, UniProt: O43488 |
Catalog # | ATGP0478 |
Price | $105, $320, $960 |
Order / More Info | Recombinant human Aldo-keto reductase 7A2/AKR7A2 protein from NKMAX Co. Ltd. |
Product Specific References | n/a |